Stannsoporfin With Light Therapy for Newborn Babies With Jaundice

NCT01887327 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Jaundice, Neonatal
Hyperbilirubinemia, Neonatal

Interventions

PROCEDURE: Phototherapy
DRUG: Stannsoporfin
DRUG: Placebo

Sponsor

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company